{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:55:22Z","timestamp":1761710122039},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.toxlet.2024.05.004","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T16:20:03Z","timestamp":1715703603000},"page":"163-173","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dabrafenib alleviates hepatotoxicity caused by lenvatinib via inhibiting the death receptor signaling pathway"],"prefix":"10.1016","volume":"397","author":[{"given":"Xinyu","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonger","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaojun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2024.05.004_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112328","article-title":"The role of natural antioxidants in cisplatin-induced hepatotoxicity","volume":"144","author":"Abd Rashid","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.toxlet.2024.05.004_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.toxlet.2024.05.004_bib3","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s40265-013-0095-2","article-title":"Dabrafenib: first global approval","volume":"73","author":"Ballantyne","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.toxlet.2024.05.004_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib5","doi-asserted-by":"crossref","first-page":"1626654","DOI":"10.1080\/20013078.2019.1626654","article-title":"Microvesicles: ROS scavengers and ROS producers","volume":"8","author":"Bodega","year":"2019","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.toxlet.2024.05.004_bib6","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/sj.onc.1209258","article-title":"Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent","volume":"25","author":"Burek","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.toxlet.2024.05.004_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/1673-5374.226394","article-title":"Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury","volume":"13","author":"Cruz","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.toxlet.2024.05.004_bib8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fendo.2018.00764","article-title":"Antineoplastic effect of lenvatinib and vandetanib in primary anaplastic thyroid cancer cells obtained from biopsy or fine needle aspiration","volume":"9","author":"Ferrari","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/1471-2407-11-309","article-title":"E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion","volume":"11","author":"Glen","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.toxlet.2024.05.004_bib10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/bcp.12907","article-title":"Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer","volume":"81","author":"Gupta","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib11","doi-asserted-by":"crossref","first-page":"1198562","DOI":"10.3389\/fimmu.2023.1198562","article-title":"Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib12","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1158\/1078-0432.CCR-15-1354","article-title":"Safety and pharmacokinetics of lenvatinib in patients with advanced hepatocellular carcinoma","volume":"22","author":"Ikeda","year":"2016","journal-title":"Clin. Cancer Res.\u00a0Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.toxlet.2024.05.004_bib13","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119610","article-title":"Modulatory effects of carvacrol against cadmium-induced hepatotoxicity and nephrotoxicity by molecular targeting regulation","volume":"277","author":"Kandemir","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.toxlet.2024.05.004_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167378","article-title":"Apoptosis, pyroptosis, and necroptosis-oh my! the many ways a cell can die","volume":"434","author":"Ketelut-Carneiro","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib16","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00204-019-02511-9","article-title":"Validation of the \u03b3H2AX biomarker for genotoxicity assessment: a review","volume":"93","author":"Kopp","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2024.05.004_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.toxlet.2017.11.020","article-title":"Comparison of hepatic transcriptome profiling between acute liver injury and acute liver failure induced by acetaminophen in mice","volume":"283","author":"Li","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2024.05.004_bib19","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1111\/jcmm.17474","article-title":"MgIG exerts therapeutic effects on crizotinib-induced hepatotoxicity by limiting ROS-mediated autophagy and pyroptosis","volume":"26","author":"Li","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.toxlet.2024.05.004_bib20","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.21873\/anticanres.15068","article-title":"Lenvatinib induces AKT\/NF-\u03baB inactivation, apoptosis signal transduction and growth inhibition of non-small cell lung cancer in vivo","volume":"41","author":"Liu","year":"2021","journal-title":"Anticancer Res."},{"key":"10.1016\/j.toxlet.2024.05.004_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.toxlet.2024.05.004_bib22","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1158\/1078-0432.CCR-07-5270","article-title":"Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase","volume":"14","author":"Matsui","year":"2008","journal-title":"Clin. Cancer Res.\u00a0Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.toxlet.2024.05.004_bib23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.23131","article-title":"E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition","volume":"122","author":"Matsui","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.toxlet.2024.05.004_bib24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03602532.2020.1832112","article-title":"The development and hepatotoxicity of acetaminophen: reviewing over a century of progress","volume":"52","author":"Mcgill","year":"2020","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.toxlet.2024.05.004_bib25","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1158\/1078-0432.CCR-15-1377","article-title":"FDA approval summary: lenvatinib for progressive, radio-iodine-refractory differentiated thyroid cancer","volume":"21","author":"Nair","year":"2015","journal-title":"Clin. Cancer Res.\u00a0Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.toxlet.2024.05.004_bib26","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1002\/onco.13566","article-title":"FDA supplemental approval summary: lenvatinib for the treatment of unresectable hepatocellular carcinoma","volume":"26","author":"Nair","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.toxlet.2024.05.004_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s13318-017-0402-5","article-title":"Prediction of tissue-to-plasma ratios of basic compounds in mice","volume":"42","author":"Nigade","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.toxlet.2024.05.004_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mam.2018.03.002","article-title":"ROS signaling and ER stress in cardiovascular disease","volume":"63","author":"Ochoa","year":"2018","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.toxlet.2024.05.004_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxlet.2024.05.004_bib30","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1111\/1346-8138.14206","article-title":"Dabrafenib and trametinib combination therapy safely performed in a patient with metastatic melanoma after severe liver toxicity due to vemurafenib","volume":"45","author":"Shimada","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jare.2022.03.012","article-title":"GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma","volume":"44","author":"Tan","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.toxlet.2024.05.004_bib33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cellsig.2003.08.007","article-title":"Death receptor-induced cell killing","volume":"16","author":"Thorburn","year":"2004","journal-title":"Cell. Signal."},{"key":"10.1016\/j.toxlet.2024.05.004_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112391","article-title":"The impact of individual human cytochrome P450 enzymes on oxidative metabolism of anticancer drug lenvatinib","volume":"145","author":"Vavrov\u00e1","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.toxlet.2024.05.004_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216122","article-title":"METTL3-m6A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.toxlet.2024.05.004_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13578-021-00640-2","article-title":"Apatinib induces endoplasmic reticulum stress-mediated apoptosis and autophagy and potentiates cell sensitivity to paclitaxel via the IRE-1\u03b1-AKT-mTOR pathway in esophageal squamous cell carcinoma","volume":"11","author":"Wang","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.toxlet.2024.05.004_bib37","article-title":"Co-treatment with resveratrol and FGF1 protects against acute liver toxicity after doxorubicin treatment via the AMPK\/NRF2 pathway","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib38","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.7150\/jca.50292","article-title":"Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT","volume":"12","author":"Ye","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.toxlet.2024.05.004_bib39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.molmed.2018.05.004","article-title":"Beyond cell death: new functions for TNF family cytokines in autoimmunity and tumor immunotherapy","volume":"24","author":"Yi","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.toxlet.2024.05.004_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13045-016-0374-y","article-title":"New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy","volume":"10","author":"Zarrabi","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.toxlet.2024.05.004_bib41","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427424000900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427424000900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T02:04:36Z","timestamp":1718244276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427424000900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":41,"alternative-id":["S0378427424000900"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.05.004","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dabrafenib alleviates hepatotoxicity caused by lenvatinib via inhibiting the death receptor signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2024.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}